ArticleBMC neurology2026
Clinical presentation and survival outcome of solitary fibrous tumors of the central nervous system: a single center study.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeSolitary fibrous tumors (SFTs) of the central nervous system (CNS) are rare mesenchymal neoplasms with unpredictable biological behavior, including a propensity for recurrence and metastasis. Due to their rarity, prognostic factors and optimal management strategies remain incompletely defined. This study aimed to evaluate the clinical characteristics and survival outcomes of patients with CNS SFT.
methodsThis single-center retrospective study included patients who underwent surgical resection for a presumed meningioma between January 2017 and December 2025 and were postoperatively diagnosed with CNS SFT. Clinical, radiological, surgical, and pathological data were reviewed, and overall survival (OS) and disease-free survival (DFS) were analyzed using the Kaplan-Meier method.
resultsEighteen patients were included (mean age 48.7 years), and gross total resection was achieved in 77.8%. During a median OS follow-up of 28.7 months, three deaths (16.7%) occurred; median OS was not reached. Adjuvant radiotherapy was associated with improved OS (p = 0.027), while postoperative neurological deficits were associated with worse OS (p = 0.011). Seventeen patients were evaluable for DFS, with a median DFS of 9.2 months and a recurrence rate of 64.7%. In multivariable Cox analysis, adjuvant radiotherapy was independently associated with reduced recurrence risk (HR 0.094, p = 0.042).
conclusionCNS SFTs demonstrate favorable overall survival but high early recurrence rates. Adjuvant radiotherapy appears to be associated with improved survival outcomes, underscoring the importance of multidisciplinary management and long-term follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.